aldosterone has been researched along with tacrolimus in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (36.36) | 18.2507 |
| 2000's | 3 (27.27) | 29.6817 |
| 2010's | 1 (9.09) | 24.3611 |
| 2020's | 3 (27.27) | 2.80 |
| Authors | Studies |
|---|---|
| Arita, S; Hamaguchi, K; Kashiwabara, H; Sakamoto, K; Yamada, K; Yokoyama, T | 1 |
| Johnson, JP; Palevsky, PM; Rokaw, MD; West, ME | 1 |
| Golbaekdal, K; Nielsen, CB; Pedersen, EB | 1 |
| Ader, JL; Cisterne, JM; Durand, D; Rostaing, L; Tack, I; Tran-Van, T | 1 |
| Aker, S; Deppe, C; Grabensee, B; Heering, P; Kinne, RK; Kinne-Saffran, E | 1 |
| Demura, M; Mabuchi, H; Takeda, Y; Usukura, M; Yoneda, T | 1 |
| Deppe, CE; Farman, N; Grabensee, B; Heering, PJ; Lombès, M; Viengchareun, S | 1 |
| Cherney, DZ; Lai, V; Moon, KH; Schulz, MZ; Zaltzman, JS | 1 |
| Ito, R; Morita, M; Nakano, T; Sato, I; Sugawara, A; Yokoyama, A | 1 |
| Klein, JD; Sands, JM; Wang, Y | 1 |
| Berber, M; Beuschlein, F; Breault, DT; Leng, S; Loffing, J; Odermatt, A; Penton, D; Wengi, A; Winter, DV | 1 |
1 trial(s) available for aldosterone and tacrolimus
| Article | Year |
|---|---|
A randomized cross-over comparison of short-term exposure of once-daily extended release tacrolimus and twice-daily tacrolimus on renal function in healthy volunteers.
Topics: 6-Ketoprostaglandin F1 alpha; Adolescent; Adult; Aldosterone; Calcineurin Inhibitors; Cross-Over Studies; Delayed-Action Preparations; Drug Administration Schedule; Healthy Volunteers; Humans; Immunosuppressive Agents; Kidney; Male; Middle Aged; Nitric Oxide; Prospective Studies; Renal Circulation; Tacrolimus; Young Adult | 2014 |
10 other study(ies) available for aldosterone and tacrolimus
| Article | Year |
|---|---|
Sodium-losing nephropathy and distal tubular damage of transplant kidneys with FK506 administration.
Topics: Aldosterone; Creatinine; Humans; Hyponatremia; Kidney Transplantation; Kidney Tubules, Distal; Prednisolone; Renin; Sodium; Tacrolimus; Time Factors; Vasopressins | 1995 |
FK-506 and rapamycin but not cyclosporin inhibit aldosterone-stimulated sodium transport in A6 cells.
Topics: Aldosterone; Biological Transport; Cell Line; Cyclosporine; Electric Conductivity; Immunosuppressive Agents; Mineralocorticoid Receptor Antagonists; Nystatin; Polyenes; Sirolimus; Sodium; Tacrolimus; Time Factors | 1996 |
The acute effects of FK-506 on renal haemodynamics, water and sodium excretion and plasma levels of angiotensin II, aldosterone, atrial natriuretic peptide and vasopressin in pigs.
Topics: Aldosterone; Angiotensin II; Animals; Atrial Natriuretic Factor; Blood Pressure; Female; Glomerular Filtration Rate; Heart Rate; Immunosuppressive Agents; Injections, Intravenous; Kidney; Lithium; Random Allocation; Sodium; Swine; Tacrolimus; Vasopressins | 1996 |
Influence of early FK 506 trough levels on glomerular hemodynamics at 3 months in kidney transplant recipients.
Topics: Adult; Aldosterone; Amino Acids; Azathioprine; Blood Pressure; Creatinine; Drug Therapy, Combination; Female; Follow-Up Studies; Glomerular Filtration Rate; Hemodynamics; Humans; Immunosuppressive Agents; Infusions, Intravenous; Kidney Transplantation; Male; Prednisone; Propranolol; Renal Circulation; Renin; Tacrolimus; Time Factors; Vascular Resistance | 1998 |
Different effects of cyclosporine a and FK506 on potassium transport systems in MDCK cells.
Topics: Aldosterone; Animals; Cell Division; Cell Line; Cell Survival; Cyclosporine; Dogs; Dose-Response Relationship, Drug; Immunosuppressive Agents; Ion Transport; Kidney Tubules, Distal; Potassium; Potassium Channel Blockers; Rubidium Radioisotopes; Sodium-Potassium-Chloride Symporters; Sodium-Potassium-Exchanging ATPase; Tacrolimus | 2001 |
Calcineurin inhibition attenuates mineralocorticoid-induced cardiac hypertrophy.
Topics: Aldosterone; Animals; Anti-Arrhythmia Agents; Antihypertensive Agents; Atrial Natriuretic Factor; Body Weight; Calcineurin; Calcineurin Inhibitors; Cardiomegaly; Collagen Type III; Cyclosporine; Enzyme Inhibitors; Fibrosis; Heart; Immunosuppressive Agents; Losartan; Male; Mineralocorticoids; Myocardium; Nephrectomy; Organ Size; Rats; Rats, Inbred WKY; RNA, Messenger; Sodium Chloride, Dietary; Tacrolimus | 2002 |
Cyclosporine a and FK506 inhibit transcriptional activity of the human mineralocorticoid receptor: a cell-based model to investigate partial aldosterone resistance in kidney transplantation.
Topics: Aldosterone; beta-Galactosidase; Blotting, Northern; Cyclosporine; Depression, Chemical; Genes, MDR; Glyceraldehyde-3-Phosphate Dehydrogenases; Humans; Immunosuppressive Agents; Kidney Transplantation; Kidney Tubules; Luciferases; Mineralocorticoid Receptor Antagonists; Models, Biological; Pseudohypoaldosteronism; Receptors, Mineralocorticoid; Reverse Transcriptase Polymerase Chain Reaction; Signal Transduction; Steroids; Subcellular Fractions; Tacrolimus; Transcription, Genetic; Transfection | 2002 |
The establishment of a novel high-throughput screening system using RNA-guided genome editing to identify chemicals that suppress aldosterone synthase expression.
Topics: Adrenal Cortex; Aldosterone; Base Sequence; Calcium Signaling; Cell Line; Cytochrome P-450 CYP11B2; Drug Evaluation, Preclinical; Gene Editing; Gene Expression Regulation, Enzymologic; Genes, Reporter; High-Throughput Screening Assays; Humans; Hyperaldosteronism; RNA, Guide, Kinetoplastida; RNA, Messenger; Steroid 11-beta-Hydroxylase; Tacrolimus | 2021 |
Phosphatases Decrease Water and Urea Permeability in Rat Inner Medullary Collecting Ducts.
Topics: Adrenomedullin; Aldosterone; Animals; Aquaporin 2; Calcineurin; Kidney Tubules, Collecting; Membrane Transport Proteins; Permeability; Phosphoric Monoester Hydrolases; Rats; Rats, Sprague-Dawley; Tacrolimus; Urea; Vasopressins; Water | 2023 |
Calcineurin regulates aldosterone production via dephosphorylation of NFATC4.
Topics: Aldosterone; Animals; Calcineurin; Cytochrome P-450 CYP11B2; Humans; Hyperkalemia; Mice; NFATC Transcription Factors; Tacrolimus | 2023 |